EM, B., DR, B., P, H., & R, B. (2004). Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 38(6), 771. https://doi.org/10.1086/381548
Chicago Style (17th ed.) CitationEM, Begier, Burwen DR, Haber P, and Ball R. "Postmarketing Safety Surveillance for Typhoid Fever Vaccines from the Vaccine Adverse Event Reporting System, July 1990 Through June 2002." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 38, no. 6 (2004): 771. https://doi.org/10.1086/381548.
MLA (9th ed.) CitationEM, Begier, et al. "Postmarketing Safety Surveillance for Typhoid Fever Vaccines from the Vaccine Adverse Event Reporting System, July 1990 Through June 2002." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 38, no. 6, 2004, p. 771, https://doi.org/10.1086/381548.